Istradefylline forty mg/day enhanced peak concentrations and AUC of CYP3A4 substrates in scientific trials. This result was not noticed with istradefylline twenty mg/day. Consider dose reduction of sensitive CYP3A4 substrates.Prevent concomitant usage of tucatinib with CYP3A substrates, wherever small focus alterations may well bring on critical or